Dolby Laboratories (DLB) Tops Q1 EPS by 61c, Offers Guidance
Get Alerts DLB Hot Sheet
EPS Growth %: -28.6%
Financial Fact:
Total revenue: 233M
Today's EPS Names:
ESCA, LICT, NKSH, More
Join SI Premium – FREE
Dolby Laboratories (NYSE: DLB) reported Q1 EPS of $1.11, $0.61 better than the analyst estimate of $0.50. Revenue for the quarter came in at $334.9 million versus the consensus estimate of $307.94 million.
GUIDANCE:
Dolby Laboratories sees Q2 2023 EPS of $0.90-$1.05, versus the consensus of $0.93. Dolby Laboratories sees Q2 2023 revenue of $340-370 million, versus the consensus of $332.1 million.
Dolby is providing the following high-level estimates for the full year of fiscal 2023
- Total revenue is expected to grow low single digits year-over-year.
- GAAP operating expenses are expected to decline roughly 2% year-over-year. Non-GAAP operating expenses are expected to grow roughly 2% year-over-year.
- We expect operating margins on a GAAP basis to be roughly 19% and on a non-GAAP basis to be roughly 30%.
Dolby is providing the following estimates for its second quarter of fiscal 2023:
- Total revenue is estimated to range from $340 million to $370 million.
- Operating expenses are anticipated to range from $227 million to $237 million on a GAAP basis and from $193 million to $203 million on a non-GAAP basis.
- Effective tax rate is anticipated to range from 22% to 24% on a GAAP basis and 19% to 21% on a non-GAAP basis.
- Diluted earnings per share is anticipated to range from $0.58 to $0.73 on a GAAP basis and from $0.90 to $1.05 on a non-GAAP basis.
For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Iridium Communications (IRDM) Reports In-Line Q1 EPS; offers outlook
- Infosys Limited (INFY) Misses Q4 Revenue
- Westamerica Bancorp. (WABC) Reports In-Line Q1 EPS
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!